Key result
In elderly patients with multivessel coronary artery disease, higher heart rate variability (e.g., SDNN 68.3 ms vs 43.2 ms, p=0.000) was significantly associated with freedom from adverse cardiovascular events at one year following PCI or optimal drug therapy.
Why the study?
The study was conducted to evaluate the prognostic value of heart rate variability in elderly patients with multivessel coronary artery disease undergoing invasive or non-invasive treatment.
Does heart rate variability predict one-year clinical complications in elderly patients with multivessel coronary artery disease undergoing PCI, CABG, or medical therapy?
Observational (n=254)
No
Does heart rate variability predict one-year clinical complications in elderly patients with multivessel coronary artery disease undergoing PCI, CABG, or medical therapy?
Absolute Event Rate: 43.2% vs 68.3%
p-value: p=0.000
Heart rate variability is a useful non-invasive prognostic marker for one-year clinical outcomes in elderly patients with multivessel CAD treated with PCI or medical therapy, but its utility is limited in the first year following CABG.
Supports HRV as prognostic marker in elderly multivessel CAD; hypothesis-generating and requires prospective validation before practice change.
The purpose of this study was to evaluate the prognostic value of HRV in elderly patients with multivessel coronary artery disease (MVCAD) on the background of invasive and non-invasive treatment. Methods and Results: This study included 254 patients over age 65 with lesions of the left trunk of the left coronary artery in combination with lesions of 2 or more coronary arteries. To assess HRV, all patients underwent 24-hour Holter ECG monitoring at baseline and one year later. Depending on the treatment strategy, patients were divided into 3 groups. Group 1 consisted of 99 patients who, in addition to the standard treatment, underwent PSI (from 1 to 4 stents); Group 2 included 86 patients who, in addition to the standard treatment, underwent CABG (from 2 to 4 shunts); Group 3 included 69 patients who received only optimal drug therapy (ODT). The results have shown that a decrease in HRV is an independent predictor of complications associated with an increase in coronary insufficiency in CAD patients. Such indicators of HRV as SDNN, SDNNi, TP, VLF, and LF have a significant positive predictive value in patients undergoing ODF and/or undergoing PCI. For patients undergoing CABG, at least in the first year after surgery, HRV cannot be considered as an independent prognostic marker. For elderly patients with MVCAD, 24-hour Holter ECG monitoring with subsequent analysis of HRV is recommended to assess the recovery process and pharmacotherapy.
No takes yet. Share an insight, caveat, or question.
Abdullaeva et al. (2021) conducted an observational in Multivessel coronary artery disease (n=254). Decreased heart rate variability vs. Preserved heart rate variability was evaluated on SDNN (ms) at one year in PCI patients who reached adverse clinical endpoints versus those who did not (p=0.000). In elderly patients with multivessel coronary artery disease, higher heart rate variability (e.g., SDNN 68.3 ms vs 43.2 ms, p=0.000) was significantly associated with freedom from adverse cardiovascular events at one year following PCI or optimal drug therapy.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: